Abstract
This study was designed to evaluate the efficacy and safety of Ziabites on glycemic control in type 2 diabetic patients. The samples consisted of 31 subjects and the doses of Ziabites were equally administered orally in the form of capsule before the breakfast, lunch and dinner. The doses were given for 4 weeks. Ziabites capsule contains Portulaca oleracea L.Rhus coriaria L. and Punica granatum L. The efficacy was assessed on the basis of the following parameters: fasting blood glucose (FBG), 2 h postprandial plasma glucose (2hppG), serum fructosamine, triglyceride (TG) and total cholesterol (Tc) levels. Also, side effects were assessed by history and physical and biochemical examinations. All of the assays were performed on the starting day of study and after 4 weeks. After 4 weeks of treatment with Ziabites capsule, there was a significant decrease (P 0.05). This study indicated that Ziabites capsule is effective in decreasing fasting and postprandial plasma glucose levels among type 2 diabetic patients without any side effects. Key words: Ziabites, Portulaca oleracea L., Rhus coriaria L., Punica granatum L., diabetes mellitus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
